The Ehlers-Danlos syndrome (EDS) is an inherited defect of connective tissue, which combines hyperextensible fragile skin and loose jointedness with a bruising and bleeding tendency. Though earlier authors (Tschernogobow, 1892; Ehlers, 1901 ;  Danlos, 1908) considered it a homogeneous disorder, 7 types are now recognized (McKusick, 1972) which vary in severity, in inheritance, and in the underlying molecular defects. Johnson and Falls (1949) first described autosomal dominant inheritance, though McKusick (1959) suspected that the disorder was heterogeneous. Barabas (1967) described 3 autosomal dominant varieties and Beighton et al. (1969) 5 , one of which was inherited as a sex-linked recessive character. More recently 2 autosomal recessive variants have been added (Pinnell et al., 1972; Lichtenstein et al., 1973) . Specific biochemical defects have been identified in EDS types V, VI, and VII. Type V only affects males and is inherited as a sex-linked recessive trait. Cultured fibroblasts from such patients are deficient in lysyl oxidase (Di Ferrante et al., 1975) . Type VI combines specific clinical features such as loose jointedness, scoliosis, and retinal detachment, with type I collagen which is low in hydroxylysine (Pinnell et al., 1972) . Type VII shows extreme joint laxity and short stature with the persistence of precursor forms of type I collagen (procollagen) (Fig. 1) . We have studied tissues from 5 such patients; all lack type III collagen (Pope et al., 1975) . Moreover, cultured skin fibroblasts from these patients produce only type I collagen, in contrast to normal control cells which synthesise both types I and III. The extreme fragility of skin, blood vessels, intestines, and other organs in the absence of type III collagen implies an essential structural role for it.
Here we report on levels of type III collagen in skin samples and type III collagen synthesis by skin fibroblasts in various relatives of 3 affected patients. The pedigree patterns of such biochemical studies allow us to deduce the genetics of this disorder. Subjects and methods We have previously reported on 5 individuals with EDS type IV (Pope et al., 1975 The proposita, aged 17, had the usual history of excessive bruising and bleeding. A large spontaneous haemorrhage of the intestinal wall had produced acute intestinal obstruction. Other family members were normal.
BIOCHEMICAL STUDIES
The amount of type I and III collagens were estimated after digestion of the tissue with cyanogen bromide (Miller et al., 1971) . The peptides produced were resolved in part electrophoresis in sodium dodecyl sulphate on 7-5yo polyacrylamide gels.
Peptidyl material was localized in the gels by the uptake of stain after exposure to Coomassie blue and subsequent removal of unbound dye (Furthmayr and Timpl, 1971) . Authentic samples of type I and lII collagen were prepared by standard methods from fetal skin (Chung and Miller, 1974; Epstein, 1974; Trelstad et al., 1974) . The patterns of peptides produced from skin by digestion with cyanogen bromide were compared with the peptides produced from these standards. In addition, we used authentic aI(III)-CB8 (the kind of gift of Dr Ervin Epstein) as a standard.
FIBROBLAST STUDIES
Cell strains were obtained from the American Type Culture Collection of mutant Human Strains. Confluent cultures of these cells were exposed to media containing 20 ,uCi each of 14C-glycine and 14C-proline. The medium lacked carrier lysine, glycine, and proline and was supplemented with ascorbic acid and ,B-aminopropionitrile as previously described. After a 24-hour labelling period, the medium was removed from each culture and collagenous protein precipitated by the addition of (NH4)2S04 to a 20%. saturation (Church et al., 1973) . The precipitated materials were dissolved in 0 05 M Tris-HCl, pH 7-4 and type I procollagen was resolved from type III procollagen by chromatography on DEAE-cellulose (Church et al., 1974; Smith et al., 1972 Smith et al., ). 203 et al., 1974 Smith et al., 1972; Layman et al., 1971; Lichtenstein et al., 1975) . While EDS IV cell strains produce only type I procollagen, all others so far examined produce both type I and type III procollagens (Church et al., 1974; Lichtenstein et al., 1975) . We observed similar results here (Fig. 5) .
Results
After digestion with CNBr at least on peptide produced from type III collagen, cl(III)-CB8 can be readily resolved from peptides produced from type I collagen. In our previous study, we showed that this peptide was not detectable in digests of skin and the other tissues from 5 ED-IV patients (Pope et al., 1975) . Similar results were obtained here. Surprisingly, when the peptides produced from the skin of certain apparently normal family members were examined at normal sample loads, the type III collagen specific peptide was not seen (Fig. 3) . However, when the amount of protein applied to the gel was increased, we could detect aI(III)-CB8 (Fig. 4) . In general, twice to three times as much digest was required to obtain levels of aI(III)-CB8 comparable to those obtained from normal controls. Tissue from still other family members produced normal levels of I(III)-CB8 while none of this peptide was observed at any sample load from digests of EDS IV tissue.
Most of the collagenous protein produced in culture by cells obtained from skin biopsies accumulates in the culture media as procollagens (Church (Gay et al., 1975) .
The tissue weakness observed in patients with the EDS IV syndrome is caused by a lack of type III collagen. Some apparently normal relatives of 3 patients with this disorder have lower than normal levels of type III collagen in their skin. Their fibroblasts make less type III collagen relative to type I collagen than normal cell strains. Still other family members have normal cutaneous levels of type III collagen and their cell strains make a normal proportion of type I and III collagens (Fig. 5) . We interpret these results to mean that in these families EDA IV is transmitted as an autosomal recessive trait. Obligate heterozygotes are clinically undistinguished but do not make or have a normal amount of type III collagen. Earlier authors have suggested that EDS IV is transmitted as an autosomal dominant trait (Barabas, 1967; Beighton, 1970) . Undoubtedly, the patients described by them are heterogeneous, some have the disorder which we have studied while others do not. Of course, it is possible that a deficiency of type III collagen could occur in other families as autosomal dominant defects. There are obvious parallels between our disorder and the thalassaemias. Both have the complete absence of an essential protein in affected individuals with intermediate levels in heterozygotes. In contrast to the thalassaemias the obligate heterozygotes of EDS IV show little or no clinical defect.
